FDA delays colorectal cancer decision for Amgen’s Lumakras, a setback in race with Bristol Myers. News release. Endpoints News. October 17, 2024 …
FDA Pushes Back Decision on Sotorasib/Panitumumab in Colorectal Cancer
Share This Story, Choose Your Platform!
About the Author:
